20 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/first-patient-randomized-in-jaguar-healths-phase-2-randomized-double-1029830
07 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-provides-overview-of-2025-crofelemer-related-catalysts-1024559
30 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/proof-of-concept-results-show-crofelemer-reduced-total-parenteral-nut-1021550
29 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/reminder-jaguar-health-hosting-april-30-investor-webcast-to-present-i-1021431
28 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-to-present-initial-results-from-the-proof-of-concept-st-1020349
27 Mar 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-meeting-with-fda-regarding-results-of-phase-3-ontarget-1005216